3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Vomiting
27
Nausea
20
Neoplasms
8
Breast Neoplasms
6
Lymphoma
3
Stomach Neoplasms
2
Rectal Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Leukemia
2
Hematologic Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms, Male
2
Weight Loss
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Sarcoma
1
Pancreatic Neoplasms
1
Pain
1
Neoplasms, Germ Cell and Embryonal
1
Multiple Myeloma
1
Melanoma
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Inflammatory Breast Neoplasms
1
Hematologic Diseases
1
Glioma
1
Genital Neoplasms, Female
1
Gastrointestinal Neoplasms
1
Interventions
Oxaliplatin
18
Surveys and Questionnaires
15
Fluorouracil
15
Capecitabine
13
Leucovorin
12
Blood Specimen Collection
11
Irinotecan
10
Standard of Care
7
Cisplatin
7
Endoscopic Mucosal Resection
6
atezolizumab
5
Specimen Handling
5
Radiotherapy
5
Educational Status
5
Drug Therapy
5
Docetaxel
5
S 1 (combination)
4
Radiosurgery
4
Nivolumab
4
Magnetic Resonance Spectroscopy
4
Interviews as Topic
4
Gemcitabine
4
Everolimus
4
Colonoscopy
4
Biopsy
4
Bevacizumab
4
tegafur-gimeracil-oteracil
3
pemigatinib
3
apatinib
3
Remote Patient Monitoring
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Gastrointestinal Neoplasms
×
Palonosetron
×
Clear all
NCT03674294
2023-02-08
CINV
Sun Yat-sen University
Phase 3
Completed
248 enrolled